Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs HBM✓SelectedUSD · HBMMRNA vs HBM performance historyLatest closeAs of-4.84%11/18
Stock and ETF performance explorer

MRNA vs HBM

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+149.2%
HBM return
+316.5%
Excess return
-167.3%
Maximum drawdown
-86.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioHBMExcessAlpha
1D-4.8%-8.6%+3.7%-1.7%
7D-20.9%-17.7%-3.1%-15.0%
30D-13.3%-24.5%+11.3%-3.5%
3M+212.6%-31.6%+244.2%+260.1%
6M+309.0%-25.6%+334.6%+353.4%
YTD+567.3%-9.0%+576.3%+587.4%
1Y+689.7%+19.6%+670.1%+654.6%
All+149.2%+316.5%-167.3%+40.7%

Cumulative growth

Daily Returns

Daily percentage return beside HBM.

Daily Out/Under-Performance

Portfolio return minus HBM return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × HBM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded HBM wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling